GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (NSE:BROOKS) » Definitions » Net Margin %

Brooks Laboratories (NSE:BROOKS) Net Margin % : -54.20% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Brooks Laboratories Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Brooks Laboratories's Net Income for the three months ended in Mar. 2024 was ₹-96.1 Mil. Brooks Laboratories's Revenue for the three months ended in Mar. 2024 was ₹177.2 Mil. Therefore, Brooks Laboratories's net margin for the quarter that ended in Mar. 2024 was -54.20%.

The historical rank and industry rank for Brooks Laboratories's Net Margin % or its related term are showing as below:

NSE:BROOKS' s Net Margin % Range Over the Past 10 Years
Min: -35.26   Med: -24.72   Max: 13.29
Current: -23.71


NSE:BROOKS's Net Margin % is ranked worse than
74.46% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 3.065 vs NSE:BROOKS: -23.71

Brooks Laboratories Net Margin % Historical Data

The historical data trend for Brooks Laboratories's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brooks Laboratories Net Margin % Chart

Brooks Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.26 -25.15 -21.44 -33.05 -24.65

Brooks Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -32.80 -33.79 -6.73 -17.84 -54.20

Competitive Comparison of Brooks Laboratories's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Brooks Laboratories's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brooks Laboratories's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brooks Laboratories's Net Margin % distribution charts can be found below:

* The bar in red indicates where Brooks Laboratories's Net Margin % falls into.



Brooks Laboratories Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Brooks Laboratories's Net Margin for the fiscal year that ended in Mar. 2024 is calculated as

Net Margin=Net Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=-195.919/794.861
=-24.65 %

Brooks Laboratories's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-96.058/177.217
=-54.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brooks Laboratories  (NSE:BROOKS) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Brooks Laboratories Net Margin % Related Terms

Thank you for viewing the detailed overview of Brooks Laboratories's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Brooks Laboratories (NSE:BROOKS) Business Description

Traded in Other Exchanges
Address
Off. Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093
Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. It has manufacturing sites located in Baddi, Himachal Pradesh, and Vadodara, Gujarat. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.

Brooks Laboratories (NSE:BROOKS) Headlines

No Headlines